Arbeitspapier
Price Dynamics of Swedish Pharmaceuticals
This paper investigates price patterns of off-patent pharmaceuticals in Sweden. I show that price dynamics are dependent on the number of competitors in the market. The price patterns follow predictions from a model of dynamic price competition in which the demand for pharmaceuticals incorporates the known biases of consumers: habit persistence and brand preferences. Using the regulated market of Swedish pharmaceuticals, I show that price may help in identifying possible tacit collusion by manufacturers in markets where consumers experience behavioral frictions.
- Sprache
-
Englisch
- Erschienen in
-
Series: IFN Working Paper ; No. 1325
- Klassifikation
-
Wirtschaft
Market Structure, Pricing, and Design: Oligopoly and Other Forms of Market Imperfection
Analysis of Health Care Markets
Oligopoly and Other Imperfect Markets
Antitrust Issues and Policies: General
- Thema
-
Pharmaceutical pricing
Dynamic oligopoly
State dependence
Price cycles
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Janssen, Aljoscha
- Ereignis
-
Veröffentlichung
- (wer)
-
Research Institute of Industrial Economics (IFN)
- (wo)
-
Stockholm
- (wann)
-
2020
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Janssen, Aljoscha
- Research Institute of Industrial Economics (IFN)
Entstanden
- 2020
Ähnliche Objekte (12)
External price benchmarking vs. price negotiation for pharmaceuticals
Price Regulation and Parallel Imports of Pharmaceuticals
International research networks in pharmaceuticals: Structure and dynamics
Regulation and pricing of pharmaceuticals: reference pricing or price cap regulation?
Energy Usage and Energy Prices in Swedish Manufacturing
Swedish Export Price Determination: Pricing to Market Shares?
Logit price dynamics
Are There Price Bubbles in the Swedish Equity Market?
Prices, margins and liquidity constraints: Swedish newspapers 1990 - 1996
Pioneering price level targeting: The Swedish experience 1931-37
Reference pricing of pharmaceuticals
The price of inattention: Evidence from the Swedish housing market
External price benchmarking vs. price negotiation for pharmaceuticals
Price Regulation and Parallel Imports of Pharmaceuticals
International research networks in pharmaceuticals: Structure and dynamics
Regulation and pricing of pharmaceuticals: reference pricing or price cap regulation?
Energy Usage and Energy Prices in Swedish Manufacturing
Swedish Export Price Determination: Pricing to Market Shares?
Logit price dynamics
Are There Price Bubbles in the Swedish Equity Market?
Prices, margins and liquidity constraints: Swedish newspapers 1990 - 1996
Pioneering price level targeting: The Swedish experience 1931-37
Reference pricing of pharmaceuticals
The price of inattention: Evidence from the Swedish housing market
External price benchmarking vs. price negotiation for pharmaceuticals
Price Regulation and Parallel Imports of Pharmaceuticals
International research networks in pharmaceuticals: Structure and dynamics
Regulation and pricing of pharmaceuticals: reference pricing or price cap regulation?
Energy Usage and Energy Prices in Swedish Manufacturing
Swedish Export Price Determination: Pricing to Market Shares?
Logit price dynamics
Are There Price Bubbles in the Swedish Equity Market?
Prices, margins and liquidity constraints: Swedish newspapers 1990 - 1996
Pioneering price level targeting: The Swedish experience 1931-37
Reference pricing of pharmaceuticals